BamSEC and AlphaSense Join Forces
Learn More

Spyre Therapeutics Inc. – Transcripts

NASDAQ: SYRE    
Share price (11/6/26): $103.86    
Market cap (11/6/26): $9.863 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 10/05/26 Spyre Therapeutics, Inc. Presents at Citigroup’s Biopharma Back to School Summit 2026, Sep-09-2026 10:00 AM 09/09/26
Other Revised 06/08/26 Spyre Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:00 AM 06/08/26
Other Revised 04/20/26 Spyre Therapeutics, Inc. - Special Call 04/13/26
Other Revised 03/11/26 Spyre Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08:40 AM 03/09/26
Other Revised 03/10/26 Spyre Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 03:10 PM 03/03/26
CY 2025
Other Revised 06/17/25 Spyre Therapeutics, Inc. - Special Call 06/17/25
Other Revised 06/09/25 Spyre Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 09:20 AM 06/09/25
Other Revised 06/04/25 Spyre Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08:10 AM 06/04/25
CY 2024
Other Revised 11/12/24 Spyre Therapeutics, Inc. - Special Call 11/12/24
CY 2023
M&A Revised 06/23/23 Aeglea BioTherapeutics, Inc. - M&A Call 06/22/23
CY 2022
Other Revised 10/27/22 Aeglea BioTherapeutics, Inc. - Special Call 10/27/22
Other Revised 02/03/22 Aeglea BioTherapeutics, Inc. - Special Call 02/03/22
Other Revised 01/12/22 Aeglea BioTherapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 10:30 AM 01/12/22
CY 2021
Other Revised 12/06/21 Aeglea BioTherapeutics, Inc. - Special Call 12/06/21
Other Revised 06/08/21 Aeglea BioTherapeutics, Inc. - Shareholder/Analyst Call 06/08/21
Other Revised 01/13/21 Aeglea BioTherapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM 01/13/21
CY 2020
Other Revised 06/08/20 Aeglea BioTherapeutics, Inc. - Shareholder/Analyst Call 06/08/20
Other Revised 01/15/20 Aeglea BioTherapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 02:30 PM 01/15/20
CY 2019
Other Revised 09/03/19 Aeglea BioTherapeutics, Inc. - Special Call 09/03/19
Other Revised 04/08/19 Aeglea BioTherapeutics, Inc. - Special Call 04/08/19
Earnings Revised 03/07/19 Aeglea BioTherapeutics, Inc., Q4 2018 Earnings Call, Mar 07, 2019 03/07/19
CY 2018
Other Revised 12/11/18 Aeglea BioTherapeutics, Inc. - Special Call 12/11/18
Other Revised 10/17/18 Aeglea BioTherapeutics, Inc. - Special Call 10/17/18
Other Revised 09/04/18 Aeglea BioTherapeutics, Inc. - Special Call 09/04/18
Other Revised 05/22/18 Aeglea BioTherapeutics, Inc. Presents at 2018 UBS Global Healthcare Conference, May-22-2018 08:30 AM 05/22/18
Other Revised 04/12/18 Aeglea BioTherapeutics, Inc. - Special Call 04/12/18
Earnings Revised 03/13/18 Aeglea Biotherapeutics, Inc., Q4 2017 Earnings Call, Mar 13, 2018 03/13/18